115 related articles for article (PubMed ID: 8284869)
21. Outcome of radical prostatectomy for incidental carcinoma of the prostate.
Melchior S; Hadaschik B; Thüroff S; Thomas C; Gillitzer R; Thüroff J
BJU Int; 2009 Jun; 103(11):1478-81. PubMed ID: 19076134
[TBL] [Abstract][Full Text] [Related]
22. Treatment of stage A1 prostate cancer: the case for observation.
Austenfeld MS
Semin Urol; 1993 May; 11(2):58-63. PubMed ID: 7689740
[TBL] [Abstract][Full Text] [Related]
23. Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies. Correlation with tumor grade, stage, PSA level, and DNA ploidy status.
Ross JS; Nazeer T; Figge HL; Fisher HA; Rifkin MD
Am J Clin Pathol; 1995 Jul; 104(1):36-41. PubMed ID: 7541934
[TBL] [Abstract][Full Text] [Related]
24. Residual prostatic tumour in the surgical bed following radical prostatectomy in organ-confined prostate cancer: possible prognostic significance.
Valotto C; Falconieri G; Pizzolitto S; Cerruto MA; Brondani G; De Gobbi A; Zattoni F
Arch Ital Urol Androl; 2011 Jun; 83(2):78-82. PubMed ID: 21826879
[TBL] [Abstract][Full Text] [Related]
25. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.
Epstein JI; Walsh PC; Carmichael M; Brendler CB
JAMA; 1994 Feb; 271(5):368-74. PubMed ID: 7506797
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcome of patients with stage T1a prostate cancer.
Chen WM; Yang CR; Ou YC; Cheng CL; Kao YL; Ho HC; Su CK; Chiu KY; Chen JT
J Chin Med Assoc; 2003 Apr; 66(4):236-40. PubMed ID: 12854876
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of transrectal ultrasound scan of the prostate with sector biopsies for 323 New Zealand men with suspicion of prostate cancer.
Smart R
N Z Med J; 1999 Dec; 112(1101):465-9. PubMed ID: 10678211
[TBL] [Abstract][Full Text] [Related]
28. [Staging and therapeutic options in local prostatic carcinoma].
Stoffel F; Forster T; Gasser TC
Ann Ital Chir; 1999; 70(5):665-70. PubMed ID: 10692785
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis, management and screening of early localised prostate cancer.
Selley S; Donovan J; Faulkner A; Coast J; Gillatt D
Health Technol Assess; 1997; 1(2):i, 1-96. PubMed ID: 9414541
[TBL] [Abstract][Full Text] [Related]
30. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
[TBL] [Abstract][Full Text] [Related]
31. [Cancer of the prostate stage T1. Incidental carcinoma. Review of the literature and an appraisal of the classification].
Leisinger HJ
Ann Urol (Paris); 1994; 28(4):229-34. PubMed ID: 7979213
[TBL] [Abstract][Full Text] [Related]
32. Management of stage T1b (A2) and stage T1c adenocarcinoma of the prostate.
Konety BR; Bahnson RR
Semin Urol Oncol; 1996 Aug; 14(3):183-94. PubMed ID: 8865482
[TBL] [Abstract][Full Text] [Related]
33. Long-term followup results after expectant management of stage A1 prostatic cancer.
Zhang G; Wasserman NF; Sidi AA; Reinberg Y; Reddy PK
J Urol; 1991 Jul; 146(1):99-102; discussion 102-3. PubMed ID: 1711592
[TBL] [Abstract][Full Text] [Related]
34. Is submission of remaining tissue necessary when incidental carcinoma of the prostate is found on transurethral resection?
McDowell PR; Fox WM; Epstein JI
Hum Pathol; 1994 May; 25(5):493-7. PubMed ID: 8200643
[TBL] [Abstract][Full Text] [Related]
35. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup.
Epstein JI; Carmichael M; Partin AW; Walsh PC
J Urol; 1993 Jun; 149(6):1478-81. PubMed ID: 8501792
[TBL] [Abstract][Full Text] [Related]
36. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
Gettman MT; Pacelli A; Slezak J; Bergstralh EJ; Blute M; Zincke H; Bostwick DG
Urology; 1999 Sep; 54(3):479-85. PubMed ID: 10475358
[TBL] [Abstract][Full Text] [Related]
37. Prognostic markers in clinically localized prostate cancer.
Pettaway CA
Tech Urol; 1998 Mar; 4(1):35-42. PubMed ID: 9568775
[TBL] [Abstract][Full Text] [Related]
38. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
Noguchi M; Stamey TA; McNeal JE; Yemoto CM
J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
[TBL] [Abstract][Full Text] [Related]
39. Retrospective study of 101 cases with incidental prostate cancer stages T1a and T1b.
Masue N; Deguchi T; Nakano M; Ehara H; Uno H; Takahashi Y
Int J Urol; 2005 Dec; 12(12):1045-9. PubMed ID: 16409608
[TBL] [Abstract][Full Text] [Related]
40. [Stage T1a prostatic cancer: long-term retrospective study of 27 patients].
Descazeaud A; Zerbib M; Conquy S; Amsellem-Ouazana D; Saighi D; Debré B
Prog Urol; 2001 Sep; 11(4):662-6. PubMed ID: 11761687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
